About IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences is a Healthcare company based in Thunder Bay (Canada) founded in 2009. It operates as a speciality company that extracts polyclonal antibodies from chicken eggs for nutraceutical and pharmaceutical applications. IgY Immune Technologies & Life Sciences has raised $65.1 thousand across 1 funding round. Its chief executive is Terry Dyck. IgY Immune Technologies & Life Sciences offers products and services including Muno-IgY. Its focus areas include Life Sciences, Nutraceuticals Tech, Nutraceutical Ingredients and Functional Food Ingredients. Its legal entity is IGY Immune Technologies and Life Sciences Inc. Its competitors include Newtricious, Microcore, BiovaBIO and Nutriom.
Company details
IgY Immune Technologies Life Sciences was founded in 2009 in Thunder Bay, Canada, focusing on biotechnology. Polyclonal IgY antibodies are derived from chicken eggs for human and animal applications in nutraceuticals and pharmaceuticals. These products support sectors including medicine, functional foods, agriculture, and cosmeceuticals, with non-specific types used in general supplements and specific types targeted at vaccine-resistant pathogens. The company was deemed deadpooled as of March 2018.
- Headquarters Thunder Bay, Canada
- SectorsHealthcare
- Website igylifesciences.com
- Social LinkedIn Facebook
- Legal Name Igy Immune Technologies And Life Sciences Inc
- Total Equity Funding$65.1K (USD)
in 1 rounds
- Latest Funding Round$65.1K (USD), Seed
Feb 2012
Products & Services of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences offers a comprehensive portfolio of products and services, including Muno-IgY.
Purified IgY protein for immune and gut health support
Funding Insights of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences has successfully raised a total of $65.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $65.1 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $65,100
- Total Rounds 1
- Last Round Seed — $65,100
- First Round $65,100
(Feb 2012)
All 1 funding rounds of IgY Immune Technologies Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2012 | $65,100 | Seed | – | – | – |
People of IgY Immune Technologies & Life Sciences
1 people are tracked at IgY Immune Technologies & Life Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Terry Dyck | CEO | Leadership |
Complete people profiles for IgY Immune Technologies & Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IgY Immune Technologies & Life Sciences
2 dated milestones of IgY Immune Technologies & Life Sciences across 3 years, from founding to its latest funding, stage changes and deals.
- Founded IgY Immune Technologies & Life Sciences is founded.
- Funding First funding round of $65K.
Competitors of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences has 4 listed competitors in our database. They include Newtricious, Microcore, BiovaBIO and Nutriom, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| newtricious.nl | 2006 | Maastricht, Netherlands | – | – | Egg-based active ingredients are supplied for functional foods. | |
| microcoreresearch.com | 2007 | Erode, India | – | 16 | Develops and manufactures nutritional ingredients and medical foods for health applications. | |
| biovabio.com | 2020 | Johnston, United States | – | – | Provides nutrients from eggshell membrane for skin and hair health support. | |
| nutriom.com | 2001 | Lacey, United States | – | – | Manufactures high-quality egg white protein powder for health-conscious consumers. |
Detailed competitors of IgY Immune Technologies Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
10 companies that operate in the same segment as IgY Immune Technologies & Life Sciences (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | 910 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Igy Immune Technologies & Life Sciences
Complete news archive for IgY Immune Technologies Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences was founded in 2009 and raised its 1st funding round 3 years after it was founded.
IgY Immune Technologies & Life Sciences is headquartered in Thunder Bay, Canada. It is registered at Thunder Bay, Ontario, Canada.
Terry Dyck is the current CEO of IgY Immune Technologies & Life Sciences.
IgY Immune Technologies & Life Sciences is a funded company, having raised a total of $65.1K across 1 funding round to date. The company's 1st funding round was a Seed of $65.1K, raised on Feb 2012.
IgY Immune Technologies Life Sciences was founded in 2009 in Thunder Bay, Canada, focusing on biotechnology. Polyclonal IgY antibodies are derived from chicken eggs for human and animal applications in nutraceuticals and pharmaceuticals. These products support sectors including medicine, functional foods, agriculture, and cosmeceuticals, with non-specific types used in general supplements and specific types targeted at vaccine-resistant pathogens. The company was deemed deadpooled as of March 2018.
IgY Immune Technologies & Life Sciences's top competitors include Newtricious, Microcore and BiovaBIO.
IgY Immune Technologies & Life Sciences offers Muno-IgY.
IgY Immune Technologies & Life Sciences operates through Igy Immune Technologies And Life Sciences Inc.